Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Collegium raises $50M

    Collegium Pharmaceutical Inc. (Canton, Mass.) raised $50 million in a series D round led by new investor TPG Biotech. New investors RA Capital, Adage Capital, Rock Springs Capital, EcoR1 Capital, Eventide Asset …

    Published on 3/10/2015
  • FINANCIAL NEWS: Portola raises $99.8M in follow-on

    Portola Pharmaceuticals Inc. (NASDAQ:PTLA) raised $99.8 million through the sale of 2.5 million shares at $40 in a follow-on underwritten by Morgan Stanley; Credit Suisse; Cowen; and Sanford Bernstein. Portola proposed …

    Published on 3/10/2015
  • FINANCIAL NEWS: Aura Biosciences raises $21M series B

    Aura Biosciences Inc. (Cambridge, Mass.) raised $21 million in a series B round led by Advent Life Sciences. New investors Chiesi Ventures, Ysios Capital and Alexandria Venture Investments also participated, as did …

    Published on 3/5/2015
  • FINANCIAL NEWS: Biotech stocks rise after Pharmacyclics takeout

    The BioCentury 100 rose 185.74 to 7,092.82 on Thursday, driven by gains among oncology and specialty pharma stocks on news of the $21 billion acquisition of Pharmacyclics Inc. (NASDAQ:PCYC) by AbbVie Inc. (NYSE:ABBV). …

    Published on 3/5/2015
  • FINANCIAL NEWS: Venture tracks

    Karolinska Development AB (SSE:KDEV) named Jim Van heusden CEO. Van heusden was a partner at Gimv from 2007 to 2013 before founding his own firm, bioskills bvba. Van heusden succeeds Bruno Lucidi. Terje Kalland, who was…

    Published on 3/5/2015
  • FINANCIAL NEWS: Tesaro raises $173.4M in follow-on

    Tesaro Inc. (NASDAQ:TSRO) raised $173.4 million through the sale of 3.4 million shares at $51 in a follow-on underwritten by Citigroup; Leerink; Deutsche Bank; BMO Capital Markets; Baird; and Mizuho. Tesaro proposed the…

    Published on 3/4/2015
  • FINANCIAL NEWS: Tricida raises $30M series B

    Renal company Tricida Inc. (South San Francisco, Calif.) raised a $30 million series B round led by existing investor OrbiMed. Existing investors Sibling Capital Ventures and Limulus Venture Partners also participated.…

    Published on 3/4/2015
  • FINANCIAL NEWS: Mersana raises $35M, names Protopapas CEO

    Mersana Therapeutics Inc. (Cambridge, Mass.) raised $35 million in a series B-1 round led by existing investor New Enterprise Associates and named Anna Protopapas president and CEO.New investors Rock Springs Capital and…

    Published on 3/2/2015
  • FINANCIAL NEWS: Cardio3 raises EUR 31.7M

    Cardio3 BioSciences S.A. (Euronext:CARD) raised EUR 31.7 million ($36 million) through the sale of 713,380 shares at EUR 44.50 in a private placement with undisclosed institutional investors in the U.S. and Europe. UBS …

    Published on 2/27/2015
  • FINANCIAL NEWS: Chiasma closes $70M series E round

    Chiasma Inc. (Jerusalem, Israel) closed an oversubscribed $70 million series E round led by an undisclosed crossover fund. New investors Rock Springs Capital and Sofinnova Ventures participated, as did existing …

    Published on 2/27/2015
  • FINANCIAL NEWS: Viehbacher joins PureTech's board

    PureTech Ventures (Boston, Mass.) named former Sanofi (Euronext:SAN; NYSE:SNY) CEO Christopher Viehbacher to its board.PureTech CEO and Managing Partner Daphne Zohar said the board is involved in choosing thematic areas…

    Published on 2/27/2015
  • FINANCIAL NEWS: Illumina raises $40M for accelerator matching fund

    Illumina Inc. (NASDAQ:ILMN) raised $40 million from Viking Global Investors for its Accelerator Boost Capital fund, which will provide dollar-for-dollar matching funds for graduates of its Illumina Accelerator. The …

    Published on 2/26/2015
  • FINANCIAL NEWS: Lyric debuts with $20.4M series A

    Gastrointestinal newco Lyric Pharmaceuticals Inc. (South San Francisco, Calif.) raised $20.4 million in a series A round led by RiverVest Venture Partners; Sante Ventures; and Third Point Ventures. Aperture Venture …

    Published on 2/26/2015
  • FINANCIAL NEWS: Relypsa raises $150M in follow-on

    Metabolic and renal play Relypsa Inc. (NASDAQ:RLYP) raised $150.2 million through the sale of 3.9 million shares at $38.50. BofA Merrill Lynch; Cowen; Oppenheimer; Stifel; and Wedbush PacGrow were underwriters. Relypsa …

    Published on 2/26/2015
  • FINANCIAL NEWS: Funding roundup: Actavis, Xencor, Curis, Celldex, AMAG

    Actavis plc (NYSE:ACT), Xencor Inc. (NASDAQ:XNCR), Curis Inc. (NASDAQ:CRIS), Celldex Therapeutics Inc. (NASDAQ:CLDX) and AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) raised more than $8.9 billion in follow-on offerings on …

    Published on 2/25/2015
  • FINANCIAL NEWS: Uptake of Orexigen's Contrave outpaces rivals

    Orexigen Therapeutics Inc. (NASDAQ:OREX) said net U.S. sales of weight-loss drug Contrave naltrexone/bupropion were $6.5 million in 4Q14, its first quarter on the market.Partner Takeda Pharmaceutical Co. Ltd. (Tokyo:…

    Published on 2/25/2015
  • FINANCIAL NEWS: CNS play Prexton closes A round

    Prexton Therapeutics S.A. (Plan les Ouates, Switzerland) raised EUR 8.7 million ($9.9 million) in a series A round co-led by new investors Sunstone Capital and Ysios Capital. Existing investor MS Ventures also …

    Published on 2/24/2015
  • FINANCIAL NEWS: China's 3SBio aims to go public again

    3SBio Inc. (Shenyang, China) proposed an IPO on the Hong Kong Stock Exchange. Morgan Stanley; Goldman Sachs; and CITIC Securities International are underwriters.3SBio was traded on NASDAQ from 2007 until 2013, when …

    Published on 2/23/2015
  • FINANCIAL NEWS: amfAR launches $100M HIV initiative

    The Foundation for AIDS Research (amfAR) pledged $20 million to establish the amfAR Institute for HIV Cure Research, an academic center dedicated to curative research, and will award $80 million in complementary …

    Published on 2/20/2015
  • FINANCIAL NEWS: Bessemer unveils $1.6B fund

    Bessemer Venture Partners raised $1.6 billion for its BVP IX fund, which the firm will invest in several sectors including therapeutics and healthcare IT.BVP's portfolio includes endocrine and metabolic play Allena …

    Published on 2/19/2015
  • FINANCIAL NEWS: Lifecode raises $20.5M series A round

    Molecular diagnostics company Lifecode Inc. (Foster City, Calif.) raised $20.5 million in a series A funding led by Sequoia Capital; the Mayo Clinic; and Mayo Ventures. The company did not respond to a request for …

    Published on 2/19/2015
  • FINANCIAL NEWS: Merganser raises $28M in series A

    Hematology play Merganser Biotech Inc. (Newtown Square, Pa.) raised $28 million in a series A round led by new investor Novartis Venture Fund. New investors Frazier Healthcare; Sutter Hill Ventures; Osage University …

    Published on 2/19/2015
  • FINANCIAL NEWS: Neurocrine raises $250M in follow-on

    Neurocrine Biosciences Inc. (NASDAQ:NBIX) raised $250 million through the sale of 6.9 million shares at $36 in a follow-on underwritten by JPMorgan; Deutsche Bank; Jefferies; Barclays; Cowen; and Nomura.Last month, …

    Published on 2/19/2015
  • FINANCIAL NEWS: ACT Genomics raises $8M series A

    ACT Genomics Co. Ltd. (Taipei City, Taiwan) raised $8 million in a series A round led by President International Development, UMC Capital, Hotong Group, TaiAn Technologies and Hua Nan Venture Capital. The company …

    Published on 2/18/2015
  • FINANCIAL NEWS: Inotek raises $60M in IPO and notes offering

    Inotek Pharmaceuticals Corp. (NASDAQ:ITEK) was unchanged at $6 in its first day of trading on Wednesday after raising a combined $60 million in a downsized IPO and concurrent notes offering. Cowen; Piper Jaffray; …

    Published on 2/18/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993